Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergio Navarro

Showing results (61-70 of 62) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 62 results.
Hemasphere|June 8, 2026
Varnimcabtagene autoleucel (ARI-0001) in relapsed or refractory mantle cell lymphomaNil Albiol, Nuria Martínez-Cibrián, Amanda Isabel Pérez, et al.
The Lancet. Haematology|February 6, 2026
Varnimcabtagene autoleucel for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia in Spain (CART19-BE-02): a multicentre, single-arm, phase 2 trialValentín Ortiz-Maldonado, Núria Martínez-Cibrian, Leticia Alserawan, et al.
Pageof 7

Showing results (61-70 of 62) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 62 results.
Hemasphere|June 8, 2026
Varnimcabtagene autoleucel (ARI-0001) in relapsed or refractory mantle cell lymphomaNil Albiol, Nuria Martínez-Cibrián, Amanda Isabel Pérez, et al.
The Lancet. Haematology|February 6, 2026
Varnimcabtagene autoleucel for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia in Spain (CART19-BE-02): a multicentre, single-arm, phase 2 trialValentín Ortiz-Maldonado, Núria Martínez-Cibrian, Leticia Alserawan, et al.
Pageof 7